News

Latest

The Centers for Medicare & Medicaid Services issued an FAQ to outline COVID-19-related payment and grace period flexibilities for issuers offering coverage on the federally-facilitated exchanges and state-based exchanges on the federal platform.
The Senate released updated legislation as part of a widespread stimulus package to respond to the novel coronavirus (COVID-19) pandemic.
The National Institute of Environmental Health Sciences, part of the National Institutes of Health, has launched a website offering COVID-19 safety training resources for frontline responders, including hospital and other health care workers.
FDA said it is partnering with the European Medicines Agency (EMA) on regulatory strategies to facilitate the development of COVID-19 vaccines.
The Food and Drug Administration adjusted its import screening to expedite personal protective equipment and clarified types of PPE that can be imported without engaging with FDA.
The Department of Justice and Federal Trade Commission announced expedited procedures for reviewing the antitrust impact of joint efforts among competitors related to the novel coronavirus.
The Centers for Medicare & Medicaid Services awarded Section 1135 waivers to 11 more states, bringing the national total to 13 states who can receive relief for their Medicaid programs.
The Centers for Disease Control and Prevention recently updated prevention tactics for populations at a higher risk of contracting COVID-19.
The Centers for Disease Control and Prevention March 23 issued updated guidance clarifying that patients with COVID-19 can be discharged from a health care facility when clinically indicated.
The Federal Emergency Management Agency said that the Defense Production Act is being used to access 60,000 test kits, each with the capacity to serve approximately 300-400 patients.